BioCentury
ARTICLE | Clinical News

North American Vaccine regulatory update

May 3, 1999 7:00 AM UTC

Austria granted marketing approval for NVX's DTaP, a combined diphtheria, tetanus and acellular pertussis vaccine, and its DTaP-IPV injectable polio virus vaccine. Chiron Behring GmbH & Co. (Marburg, ...